Christophe Calvet
About Christophe Calvet
Christophe Calvet is the Worldwide Medical Director for Thoracic Cancers at Bristol Myers Squibb, with a robust background in oncology and immunology.
Current Position at Bristol Myers Squibb
Christophe Calvet currently holds the position of Worldwide Medical Director specializing in thoracic cancers at Bristol Myers Squibb. He operates in the New York City Metropolitan Area, focusing on global medical strategies and the advancement of treatments in thoracic oncology.
Career Path at Bristol Myers Squibb
Christophe Calvet has progressively advanced at Bristol Myers Squibb, having occupied several significant roles over the years. He started as a Medical Science Manager in 2015, specializing in immuno-oncology related to thoracic cancers. By 2016, he extended his role to include solid cancers and biomarkers. His expertise led him to become a Disease Area Specialist for thoracic cancers from 2018 to 2020. Following that, he served as a Worldwide Medical Specialist in Rueil-Malmaison, Île-de-France. This was followed by a position as Worldwide Medical Associate Director in New York City before his current role as Worldwide Medical Director.
Educational Background
Christophe Calvet holds multiple degrees that fortify his expertise in the medical field. He earned a Doctorate in Pharmacotechny and Biopharmacy from Université Paris Sud, along with a university degree in Biomedical Sciences from the same institution. He also has a Master’s degree in Health Engineering from Université Montpellier I. Additionally, he has university degrees from Université de Bordeaux in clinical research methods and Université Pierre et Marie Curie in the regulatory and economic environment of the biomedical field. He studied chemotherapy and cancer medical treatments at the Ecole des sciences du cancer - Gustave Roussy.
Research and Publications
Christophe Calvet has a strong background in research, having worked as a Doctoral Researcher at Gustave Roussy. He has authored numerous publications in peer-reviewed scientific journals and non-technical publications, contributing significantly to the body of knowledge in oncology and immunology. His work spans various aspects of cancer research, particularly focusing on thoracic cancers.
Professional Experience
Before his current tenure at Bristol Myers Squibb, Christophe Calvet gained valuable experience in various roles. He worked as an Apprentice Research Engineer at Sanofi and as a Research Intern at both Columbia University and Université Montpellier 2. His extensive experience spans from practical research to leading medical initiatives in the pharmaceutical industry, making him a respected figure in his field.